The Food and Drug Administration approved the preventative use of lenacapavir, made by Gilead Sciences, on Wednesday. Experts ...

Researchers from MIT and Scripps have unveiled a promising new HIV vaccine approach that generates a powerful immune response ...

Carson City Health and Human Services is recognizing the National Human Immunodeficiency Virus Testing Day on June 27 as a ...

Winnie Byanyima says her organization has lost almost 50% of its funding, a gap that is undermining global efforts to combat ...

Last month, the health minister said that more than half a million previously diagnosed people with HIV have been started on ...

A twice-yearly injection of lenacapavir would offer near-complete protection against the virus, clinical date indicate. More pharmaceutical news is about Dupixent, GLP-1 results, and more.

Clinical trials have shown that six-monthly injections of lenacapavir are almost 100 percent protective against becoming ...